Evidence map›Paper›PMID 35128319›Full record

ReviewSN comprehensive clinical medicine2022

High-Flow Nasal Oxygenation and Its Applicability in COVID Patients.

Raafay Mehmood, Zainab Mansoor, Gabriel Plamenov Atanasov, Alexei Cheian, Alina Davletova, Aman Patel, Danial Ahmed

Open access · bronzeAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in SN comprehensive clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Raafay MehmoodFirst Faculty of Medicine, Charles University, Prague, Czech Republic.ORCID 0000-0002-9213-2291
Zainab MansoorFirst Faculty of Medicine, Charles University, Prague, Czech Republic.
Gabriel Plamenov AtanasovFirst Faculty of Medicine, Charles University, Prague, Czech Republic.
Alexei CheianFirst Faculty of Medicine, Charles University, Prague, Czech Republic.
Alina DavletovaFirst Faculty of Medicine, Charles University, Prague, Czech Republic.
Aman PatelKing's College London, London, England.
Danial AhmedKing's College London, London, England.
Charles University · CZKing's College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-flow nasal oxygenation (HFNO) is a type of oxygen therapy that provides humidified and heated oxygen through a nasal cannula at much higher flow rates than standard oxygen therapy, while also allowing control over the fraction of inspired oxygen (FIO

Indexed as

AnaesthesiaCOVIDHigh-flow nasal oxygenationIntensive careOxygen therapyPre-oxygenationRespiratory failure

Identifiers

PMID35128319
PMCPMC8801314
OpenAlexW4210277642

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.